Investing Profile

Daniel Lynch

InvestorVC
Executive Chairman at GRA Venture Fund
gv.com/team/dan-lynch/Boston, Massachusetts
Photo of Daniel Lynch, GRA Venture Fund, LLC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Les Fermes ExotiQC Network
847 CONNECTIONS
Les Fermes ExotiQC Network
847 CONNECTIONS
Les Fermes ExotiQC Network
847 CONNECTIONS
Les Fermes ExotiQC Network
847 CONNECTIONS
Stromedix Inc. Network
472 CONNECTIONS
cb
$250K - $50.0M
$25.0M
4
$25.1M

Sign in to see all 3 investments on record.

Sign in with Google →
CEO ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyPresent
Chairman Of The Board Xilio Therapeutics, Inc.Present
Chairman of the Board SpringWorks TherapeuticsPresent
Chairman Of The Board Surface Oncology Inc.Present
Chairman Of The Board Blueprint MedicinesPresent
Executive Chairman Nimbus TherapeuticsPresent
Chairman Of The Board Stromedix Inc.Present
Chairman of the Board BIND TherapeuticsPresent
Board Member Ember TherapeuticsPresent
Chairman of the Board Bluebird BioPresent
Finance Bristol Myers SquibbPresent
Chairman Of The Board GRA Venture FundPresent
Chairman Of The Board Les Fermes ExotiQCPresent
Board Member GRA Venture FundPresent
Board Member Les Fermes ExotiQCPresent
Chairman of the Board GRA Venture FundPresent
Chairman of the Board Les Fermes ExotiQCPresent
Executive Chairman GRA Venture FundPresent
Executive Chairman Les Fermes ExotiQCPresent
Chairman Of The Board Digeo (founded by Paul Allen, acquired by ARRIS)Present
Board Member Stromedix Inc.Present
Board Member Digeo (founded by Paul Allen, acquired by ARRIS)Present
Chairman of the Board Stromedix Inc.Present
Chairman of the Board Digeo (founded by Paul Allen, acquired by ARRIS)Present
Executive Chairman Stromedix Inc.Present
Executive Chairman Digeo (founded by Paul Allen, acquired by ARRIS)Present
Wesleyan University Bachelor of Arts (B.A.) Mathematics
Sign in with Google →
Sign in with Google →